Patients' perception of risk and breast cancer awareness.

This publication has 12 references indexed in Scilit:

• Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.
  Journal of Clinical Oncology, 1996
• Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial
  BMJ, 1995
• Epidemiology Faces Its Limits
  Published by American Association for the Advancement of Science (AAAS) ,1995
• The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
  New England Journal of Medicine, 1995
• Should clinicians be concerned about the carcinogenic potential of tamoxifen?
  European Journal Of Cancer, 1994
• A Risk-Benefit Assessment of Tamoxifen Therapy
  Drug Safety, 1993
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
  The Lancet, 1992
• Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
  New England Journal of Medicine, 1985
• Tamoxifen as a possible chemotherapeutic agent in endometrial adenocarcinoma
  Gynecologic Oncology, 1981
• A REVIEW OF THE EPIDEMIOLOGY OF HUMAN BREAST CANCER
  Epidemiologic Reviews, 1979